Geode Capital Management’s Global Medical REIT GMRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.1M Buy
1,748,799
+50,959
+3% +$353K ﹤0.01% 2235
2025
Q1
$14.9M Buy
1,697,840
+49,861
+3% +$436K ﹤0.01% 2063
2024
Q4
$12.7M Buy
1,647,979
+25,820
+2% +$199K ﹤0.01% 2211
2024
Q3
$16.1M Buy
1,622,159
+18,209
+1% +$180K ﹤0.01% 2102
2024
Q2
$14.6M Buy
1,603,950
+38,283
+2% +$348K ﹤0.01% 2109
2024
Q1
$13.7M Buy
1,565,667
+58,272
+4% +$510K ﹤0.01% 2134
2023
Q4
$16.7M Buy
1,507,395
+66,600
+5% +$739K ﹤0.01% 2021
2023
Q3
$12.9M Buy
1,440,795
+35,258
+3% +$316K ﹤0.01% 2101
2023
Q2
$12.8M Buy
1,405,537
+40,077
+3% +$366K ﹤0.01% 2139
2023
Q1
$12.4M Buy
1,365,460
+29,770
+2% +$271K ﹤0.01% 2119
2022
Q4
$12.7M Buy
1,335,690
+17,076
+1% +$162K ﹤0.01% 2089
2022
Q3
$11.2M Buy
1,318,614
+19,683
+2% +$168K ﹤0.01% 2157
2022
Q2
$14.6M Sell
1,298,931
-31,827
-2% -$357K ﹤0.01% 1986
2022
Q1
$21.7M Buy
1,330,758
+21,427
+2% +$350K ﹤0.01% 1843
2021
Q4
$23.2M Buy
1,309,331
+42,340
+3% +$752K ﹤0.01% 1849
2021
Q3
$18.6M Buy
1,266,991
+81,420
+7% +$1.2M ﹤0.01% 2008
2021
Q2
$17.5M Buy
1,185,571
+242,959
+26% +$3.59M ﹤0.01% 2065
2021
Q1
$12.4M Buy
942,612
+90,261
+11% +$1.18M ﹤0.01% 2219
2020
Q4
$11.1M Buy
852,351
+228,266
+37% +$2.98M ﹤0.01% 2098
2020
Q3
$8.43M Buy
624,085
+25,207
+4% +$340K ﹤0.01% 2057
2020
Q2
$6.79M Buy
598,878
+19,926
+3% +$226K ﹤0.01% 2162
2020
Q1
$5.86M Buy
578,952
+123,951
+27% +$1.25M ﹤0.01% 2048
2019
Q4
$6.02M Buy
455,001
+62,925
+16% +$832K ﹤0.01% 2334
2019
Q3
$4.47M Buy
392,076
+12,895
+3% +$147K ﹤0.01% 2446
2019
Q2
$3.98M Buy
379,181
+88,275
+30% +$927K ﹤0.01% 2532
2019
Q1
$2.86M Buy
290,906
+89,456
+44% +$878K ﹤0.01% 2638
2018
Q4
$1.79M Buy
201,450
+37,973
+23% +$337K ﹤0.01% 2830
2018
Q3
$1.54M Buy
163,477
+7,386
+5% +$69.5K ﹤0.01% 3028
2018
Q2
$1.38M Buy
156,091
+12,815
+9% +$113K ﹤0.01% 3047
2018
Q1
$995K Buy
143,276
+1,690
+1% +$11.7K ﹤0.01% 3128
2017
Q4
$1.16M Buy
141,586
+13,441
+10% +$110K ﹤0.01% 3031
2017
Q3
$1.15M Buy
128,145
+96,194
+301% +$863K ﹤0.01% 3062
2017
Q2
$285K Buy
31,951
+4,220
+15% +$37.6K ﹤0.01% 3561
2017
Q1
$251K Buy
27,731
+4,323
+18% +$39.1K ﹤0.01% 3574
2016
Q4
$208K Buy
23,408
+7,408
+46% +$65.8K ﹤0.01% 3608
2016
Q3
$156K Buy
+16,000
New +$156K ﹤0.01% 3674